Lexeo Therapeutics, Inc. Common Stock (LXEO) Ownership

$2.28

south_east
-$0.28 (-10.78%)
Day's range
$2.19
Day's range
$2.43

Lexeo Therapeutics, Inc. Common Stock Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JANUS HENDERSON GROUP PLC 02/14/2025 4.34 M $28.51 M   15.31% 13.12%
CITADEL ADVISORS LLC 02/14/2025 2.72 M $17.92 M   0.00% 8.24%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/14/2025 2.21 M $14.54 M   -14.94% 6.68%
D1 CAPITAL PARTNERS L.P. 02/14/2025 2.20 M $14.50 M   -12.08% 6.67%
BLACKROCK, INC. 02/07/2025 1.82 M $11.99 M   11.76% 5.51%
EVENTIDE ASSET MANAGEMENT, LLC 02/14/2025 1.23 M $8.13 M   -33.47% 3.73%
VESTAL POINT CAPITAL, LP 02/14/2025 1.20 M $7.90 M   41.18% 3.63%
OMEGA FUND MANAGEMENT, LLC 02/14/2025 1.18 M $7.79 M   -49.72% 3.58%
BLACKSTONE INC. 02/14/2025 1.16 M $7.62 M   0.00% 3.50%
NOVO HOLDINGS A/S 02/14/2025 1.12 M $7.39 M   0.00% 3.40%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 02/18/2025 955,515 $6.29 M   -23.61% 2.89%
WOODLINE PARTNERS LP 02/14/2025 858,691 $5.65 M   0.79% 2.60%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 750,235 $4.94 M   102.54% 2.27%
VERITION FUND MANAGEMENT LLC 02/14/2025 709,900 $4.67 M   -8.67% 2.15%
SIREN, L.L.C. 02/14/2025 603,435 $3.97 M   0.00% 1.83%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 567,383 $3.73 M   2.56% 1.72%
RA CAPITAL MANAGEMENT, L.P. 02/14/2025 546,554 $3.60 M   0.00% 1.65%
IKARIAN CAPITAL, LLC 02/14/2025 499,301 $3.29 M   94.12% 1.51%
ALTIUM CAPITAL MANAGEMENT LP 02/13/2025 405,000 $2.66 M   100.00% 1.22%
DAFNA CAPITAL MANAGEMENT LLC 02/14/2025 393,083 $2.59 M   56.87% 1.19%
LAURION CAPITAL MANAGEMENT LP 02/14/2025 260,228 $1.71 M   0.00% 0.79%
NORTHERN TRUST CORP 02/14/2025 214,284 $1.41 M   7.09% 0.65%
ADAR1 CAPITAL MANAGEMENT, LLC 02/13/2025 169,505 $1.12 M   196.51% 0.51%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 147,807 $972,570   37.52% 0.45%
MILLENNIUM MANAGEMENT LLC 02/14/2025 141,951 $934,038   282.47% 0.43%
PERCEPTIVE ADVISORS LLC 02/14/2025 139,835 $920,114   0.00% 0.42%
PRIVIUM FUND MANAGEMENT B.V. 02/11/2025 138,115 $908,797   100.00% 0.42%
OPALEYE MANAGEMENT INC. 02/14/2025 130,000 $855,400   100.00% 0.39%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 76,981 $506,535   48.35% 0.23%
MORGAN STANLEY 02/14/2025 74,828 $492,368   -69.06% 0.23%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/14/2025 65,000 $427,700   100.00% 0.20%
WALLEYE CAPITAL LLC 02/13/2025 61,930 $407,499   100.00% 0.19%
SUPERSTRING CAPITAL MANAGEMENT LP 02/14/2025 52,616 $346,213   100.00% 0.16%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 36,050 $237,209   0.00% 0.11%
BANK OF AMERICA CORP /DE/ 02/14/2025 30,376 $199,873   -21.68% 0.09%
ARISTIDES CAPITAL LLC 02/13/2025 29,285 $192,695   100.00% 0.09%
RHUMBLINE ADVISERS 01/30/2025 25,197 $165,788   19.59% 0.08%
CITIGROUP INC 02/12/2025 24,924 $164,000   7.87% 0.08%
JUMP FINANCIAL, LLC 02/13/2025 20,400 $134,232   100.00% 0.06%
CAXTON CORP 02/14/2025 17,851 $117,460   0.00% 0.05%
MARSHALL WACE, LLP 02/13/2025 17,794 $117,084   100.00% 0.05%
PALE FIRE CAPITAL SE 02/13/2025 16,100 $105,938   100.00% 0.05%
ALLIANCEBERNSTEIN L.P. 02/12/2025 15,970 $105,083   0.00% 0.05%
CORTON CAPITAL INC. 02/14/2025 13,771 $90,613   100.00% 0.04%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/14/2025 13,477 $88,679   4.72% 0.04%
COREBRIDGE FINANCIAL, INC. 02/11/2025 11,715 $77,085   -7.02% 0.04%
INTECH INVESTMENT MANAGEMENT LLC 02/11/2025 11,565 $76,098   100.00% 0.04%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 11,148 $73,354   100.00% 0.03%
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. 01/24/2025 7,011 $46,132   100.00% 0.02%
02/11/2025 6,040 $39,743   100.00% 0.02%

Lexeo Therapeutics, Inc. Common Stock institutional Ownership - FAQ's

During the previous two years, 71 institutional investors and hedge funds held shares of Lexeo Therapeutics, Inc. Common Stock. The most heavily invested institutionals were:

ROTHSCHILD INVESTMENT LLC: 0

GAMMA Investing LLC: 0

JANUS HENDERSON GROUP PLC: 4.34 M

CITADEL ADVISORS LLC: 2.72 M

ADAGE CAPITAL PARTNERS GP, L.L.C.: 2.21 M

D1 Capital Partners L.P.: 2.2 M

87.86% of Lexeo Therapeutics, Inc. Common Stock stock is owned by institutional investors.

Institutional investors have bought a total of 28.27 M shares in the last 24 months. This purchase volume represents approximately $64.45 M in transactions.